IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(0.82) per share which missed the analyst consensus estimate of $(0.67) by 22.39 percent. This is a 54.72 percent decrease over losses of $(0.53) per share from the same period last year.